MSLN and ovarian carcinoma: As a single marker, mesothelin does not apply to the diagnosis of ovarian cancer, but it could complement standard diagnostic methods based on ultrasound and currently used tests or algorithms (CA125, OVA1, ROMA) and significantly improve their sensitivity [33].